Results of proteomic mass spectrometry (101) revealed that human leucine-rich alpha-2-glycoprotein 1 (LRG1) was concentrated in urine exosomes, and was expressed at higher levels in patients with NSCLC, compared with healthy individuals. The gene discussed is LRG1; the disease is non-small cell lung carcinoma.